Payment overview · 2025
General Payments
$27.82
1 reported records · 1 companies
Healthcare provider profile · identity verified
Joel Saldana, MD
Allopathic & Osteopathic Physicians|Family Medicine · KENEDY, TX · NPI 1427021997
Verified facts
What the public records show
CMS Open Payments records show Joel Saldana, MD received $27.82 in general payments during 2025 across 1 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $27.82 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $27.82 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CRENESSITY Normalized: crenessity |
Drug | Neurocrine BioSciences, Inc. | $27.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 479 | 113 |
| Gabapentin | Gabapentin | 416 | 93 |
| Levothyroxine Sodium | Levothyroxine Sodium | 411 | 81 |
| Amlodipine Besylate | Amlodipine Besylate | 337 | 76 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 330 | 86 |
| Lisinopril | Lisinopril | 315 | 81 |
| Metoprolol Succinate | Metoprolol Succinate | 295 | 65 |
| Losartan Potassium | Losartan Potassium | 283 | 67 |
| Metformin Hcl | Metformin Hcl | 273 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 272 | 65 |
| Pantoprazole Sodium | Pantoprazole Sodium | 268 | 65 |
| Potassium Chloride | Potassium Chloride | 234 | 38 |
| Furosemide | Furosemide | 229 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 183 | 45 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 169 | 115 |
| Tramadol Hcl | Tramadol Hcl | 169 | 39 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 165 | 29 |
| Carvedilol | Carvedilol | 159 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 159 | 45 |
| Donepezil Hcl | Donepezil Hcl | 155 | 25 |
| Alprazolam | Alprazolam | 147 | 29 |
| Metformin Hcl Er | Metformin Hcl | 143 | 33 |
| Amoxicillin | Amoxicillin | 142 | 117 |
| Meloxicam | Meloxicam | 139 | 39 |
| Pravastatin Sodium | Pravastatin Sodium | 128 | 32 |
| Azithromycin | Azithromycin | 127 | 92 |
| Mirtazapine | Mirtazapine | 123 | 23 |
| Mounjaro | Tirzepatide | 122 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 120 | 23 |
| Simvastatin | Simvastatin | 117 | 26 |
| Montelukast Sodium | Montelukast Sodium | 98 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 97 | 29 |
| Glimepiride | Glimepiride | 96 | 23 |
| Eliquis | Apixaban | 95 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 95 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 94 | 26 |
| Januvia | Sitagliptin Phosphate | 94 | 18 |
| Omeprazole | Omeprazole | 94 | 28 |
| Levetiracetam | Levetiracetam | 81 | 11 |
| Lorazepam | Lorazepam | 80 | 18 |
| Methylprednisolone | Methylprednisolone | 75 | 67 |
| Duloxetine Hcl | Duloxetine Hcl | 70 | 17 |
| Spironolactone | Spironolactone | 70 | 18 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 68 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 65 | 18 |
| Jardiance | Empagliflozin | 64 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 63 | 11 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 61 | 25 |
| Allopurinol | Allopurinol | 61 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 61 | 17 |
| Finasteride | Finasteride | 55 | 16 |
| Memantine Hcl | Memantine Hcl | 52 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 51 | suppressed |
| Trulicity | Dulaglutide | 49 | suppressed |
| Ramipril | Ramipril | 48 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 47 | 12 |
| Nystatin | Nystatin | 46 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 46 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 45 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 44 | suppressed |
| Glipizide | Glipizide | 43 | suppressed |
| Latanoprost | Latanoprost | 43 | suppressed |
| Prednisone | Prednisone | 42 | 15 |
| Buspirone Hcl | Buspirone Hcl | 41 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 40 | suppressed |
| Naproxen | Naproxen | 39 | 13 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 39 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 38 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 36 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 36 | suppressed |
| Atenolol | Atenolol | 34 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Ozempic | Semaglutide | 32 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 32 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 32 | 19 |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Nifedipine Er | Nifedipine | 30 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | 19 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 27 | suppressed |
| Fluconazole | Fluconazole | 25 | 15 |
| Clindamycin Hcl | Clindamycin Hcl | 24 | 19 |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | 15 |
| Famciclovir | Famciclovir | 22 | 12 |
| Olanzapine | Olanzapine | 22 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 22 | suppressed |
| Vascepa | Icosapent Ethyl | 22 | suppressed |
| Cefadroxil | Cefadroxil | 21 | 16 |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 14 |
| Estradiol | Estradiol | 21 | suppressed |
| Ezetimibe | Ezetimibe | 21 | suppressed |
| Famotidine | Famotidine | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Myrbetriq | Mirabegron | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 19 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 19 | suppressed |
| Fenofibrate | Fenofibrate | 19 | suppressed |
| Nabumetone | Nabumetone | 19 | suppressed |
| Scopolamine | Scopolamine | 19 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 17 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 12 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Fentanyl | Fentanyl | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Clonidine | Clonidine | 15 | suppressed |
| Phenytoin | Phenytoin | 15 | suppressed |
| Baclofen | Baclofen | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 14 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | 11 |
| Brilinta | Ticagrelor | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Bicalutamide | Bicalutamide | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 12 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 11 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Lacosamide | Lacosamide | 11 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $27.82 · 1 records | Neurocrine BioSciences, Inc. | CRENESSITY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error